Problem statement: Answer the multiple-choice question.
Question: Which drug exhibits a 2.616% hERG inhibition at a concentration of 10uM?
Constraint: You must select none, one or more options from a, b, c, or d without using any other words.
Options:
a) CC(C)CNC(=O)C1Nc2ccc(OC(F)(F)F)cc2C2C=CCC12
b) O=C(Nc1ccccc1)Nc1ccccc1-n1ccnc1
c) CC1(C)Cc2ccccc2-c2n[nH]c(=S)n21
d) C=CCn1c(SCc2c(F)c(F)c(F)c(F)c2F)nc(O)cc1=O
Answer: a. CC(C)CNC(=O)C1Nc2ccc(OC(F)(F)F)cc2C2C=CCC12
{#Task|Problem statement!}: Answer the {#multiple choice|multiple-choice|MCQ!} question.
{#Question|Query!}: Which {#compound|drug!} {#has|exhibits!} a {herg_central_at_10uM#}{herg_central_at_10uM__units} {herg_central_at_10uM__names__noun}?
Constraint: You must select none, one or more options from {%multiple_choice_enum%2-5%aA1} without using any {#other|additional!} words.
Options:
{SMILES%herg_central_at_10uM%}
Answer: {%multiple_choice_result}. {SMILES#}
CC(C)CNC(=O)C1Nc2ccc(OC(F)(F)F)cc2C2C=CCC12
CC(C)CNC(=O)C1Nc2ccc(OC(F)(F)F)cc2C2C=CCC12
N-(2-methylpropyl)-8-(trifluoromethoxy)-3a,4,5,9b-tetrahydro-3H-cyclopenta[c]quinoline-4-carboxamide